Llwytho...
Long-Term Management of Orbital and Systemic Reactive Lymphoid Hyperplasia with Rituximab
Rituximab, a monoclonal antibody to the B cell marker CD20, is becoming increasingly popular in the treatment of various orbital disorders. In this university-based interventional case series, we describe two patients with bilateral orbital and extra-orbital reactive lymphoid hyperplasia (RLH) treat...
Wedi'i Gadw mewn:
| Prif Awduron: | , , , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Medknow Publications & Media Pvt Ltd
2012
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3519137/ https://ncbi.nlm.nih.gov/pubmed/23248552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0974-9233.102770 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|